Wegovy, administered as a once weekly semaglutide injection, has demonstrated significant weight loss benefits, especially when paired with a reduced calorie diet and lifestyle interventions
However, if youre not achieving optimal blood sugar control, would like to lose more weight, or want to see if you can do better, switching to Ozempic may produce improved results
[9] It's important to note that Rybelsus does not have an FDA indication for cardiovascular risk reduction
This reaction converts the reduced form of glutathione (GSH) into oxidized glutathione (GSSG), which is then reduced back to GSH by glutathione reductase (GR), using electrons from NADPH (Dringen and Arend, 2025)
This is often referred to as the "GLP-1 trap": employees lose weight quickly, but the underlying behaviors don't change so as soon as the medication stops, the weight comes back
That consistency strengthens the simple answer: the Phase 3 retatrutide safety story is led by gastrointestinal effects